C.A. Migliorati, C. Madrid  Clinical Microbiology and Infection 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
Rapid streptococcal testing for sore throat and antibiotic resistance
L. Boyanova  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR
An outbreak of hospital-acquired Pseudomonas aeruginosa infection caused by contaminated bottled water in intensive care units  T. Eckmanns, M. Oppert,
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients  R. Cantón, N. Cobos,
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Clinical Microbiology and Infection
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis  G. Choudhury,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
The microarray technology: facts and controversies
Public health microbiology, a challenge for Europe
R. Cantón  Clinical Microbiology and Infection 
Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications 
Rapid streptococcal testing for sore throat and antibiotic resistance
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Clinical Microbiology and Infection
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Training for the infectious diseases speciality in Norway
G. Höffken  Clinical Microbiology and Infection 
T. Lazzarotto, B. Guerra, L. Gabrielli, M. Lanari, M.P. Landini 
Laboratory diagnosis and biosafety issues of biological warfare agents
The clinical efficacy of triclosan/copolymer and other common therapeutic approaches to periodontal health  R.M. Davies  Clinical Microbiology and Infection 
Elements of design: the knowledge on which we build
Management of Periodontal Disease in Patients with HIV
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals  H. von.
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
The practice of travel medicine in Europe
Molecular epidemiology of Pseudomonas aeruginosa in intensive care units over a 10- year period ( )  M. Cuttelod, L. Senn, V. Terletskiy, I. Nahimana,
Systematic review of antibiotic consumption in acute care hospitals
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital  R. Herruzo, F.
Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients  S. Oliveri, L. Trovato, P. Betta, M.G. Romeo,
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
Training in infectious diseases and tropical medicine in Britain
Current experience in treating invasive zygomycosis with posaconazole
Clinical infection services—the Leiden experience
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P
Comparative study of pediculicidal effect of medical plants
Abstracts Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

The interface between oral and systemic health: the need for more collaboration  C.A. Migliorati, C. Madrid  Clinical Microbiology and Infection  Volume 13, Pages 11-16 (October 2007) DOI: 10.1111/j.1469-0691.2007.01799.x Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 A patient with lymphoma receiving high-dose chemotherapy complained of severe pain and bleeding in the oral cavity. Maintenance of cancer therapy is vital for the control of the disease, and could not be discontinued at this time. (a) The referral of the patient to an oral medicine specialist prompted a rapid diagnosis of Pseudomonas aeruginosa infection. Specific antibiotic sensitivity testing led to the recommendation of a clindamycin and ciprofloxacin combination. Oral hygiene included mouth rinses with chlorhexidine and iodine in an alternate schedule. (b) Three weeks after diagnosis, the oral tissues were completely healed and the oral function was normal. The cancer therapy continued throughout the management of the oral infection and did not have to be modified or stopped. Clinical Microbiology and Infection 2007 13, 11-16DOI: (10.1111/j.1469-0691.2007.01799.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 A patient with cancer using zoledronic acid developed this area of exposed and necrotic bone in the oral tissues. The area was infected, swollen and painful, requiring antibiotic therapy and local debridement. Clinical Microbiology and Infection 2007 13, 11-16DOI: (10.1111/j.1469-0691.2007.01799.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 A patient in the intensive care unit. Observe that the endotracheal tube prevents the patient from closing the mouth, leading to xerostomia. The dry mouth is exacerbated by the action of several medications used in the medical care of the patient. Maintaining good oral hygiene, although very important, is difficult, due to the mechanical barriers, lack of patient cooperation, lack of training of nurses, and the risk of displacing the tube. This favours the colonisation of the oral tissues with pathogenic microorganisms, increasing the risk of local and systemic infections. Clinical Microbiology and Infection 2007 13, 11-16DOI: (10.1111/j.1469-0691.2007.01799.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions